The RAF cysteine-rich domain: Structure, function, and role in disease

Area of Science:

• Molecular Biology
• Cell Signaling
• Biochemistry

Background:

• RAF kinases (ARAF, BRAF, CRAF) are crucial RAS-MAPK pathway effectors.
• BRAF mutations drive cancer; germline mutations cause RASopathies.
• Targeting RAF function is challenging due to its complex activation cycle.

Purpose of the Study:

• To review the regulatory roles of the RAF cysteine-rich domain (CRD).
• To elucidate the interplay of CRD's opposing functions in RAF activation.
• To identify novel therapeutic strategies targeting RAF function.

Main Methods:

• Review of recent structural and biochemical studies.
• Analysis of CRD's role in RAS-RAF interaction and autoinhibition.
• Comparison of BRAF CRD and CRAF CRD functional differences.

Main Results:

• The CRD binds lipids (phosphatidylserine) and RAS, promoting RAF activation.
• The CRD also maintains RAF in a closed, autoinhibited state under quiescent conditions.
• Functional distinctions exist between BRAF and CRAF CRDs.

Conclusions:

• The CRD's dual role is critical for RAF regulation.
• Understanding CRD function offers new avenues for therapeutic intervention in RAF-driven diseases.
• Further research into CRD mechanisms can inform targeted drug development.